Scope Fluidics SA (WAR:SCP) — Market Cap & Net Worth
Market Cap & Net Worth: Scope Fluidics SA (SCP)
Scope Fluidics SA (WAR:SCP) has a market capitalization of $94.68 Million (zł344.01 Million) as of September 16, 2026. Listed on the WAR stock exchange, this Poland-based company holds position #19465 globally and #153 in its home market, demonstrating a 1.45% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Scope Fluidics SA's stock price zł126.20 by its total outstanding shares 2725930 (2.73 Million). Also see Scope Fluidics SA total assets for a full breakdown of the balance sheet.
Scope Fluidics SA Market Cap History: 2017 to 2026
Scope Fluidics SA's market capitalization history from 2017 to 2026. Data shows growth from $10.88 Million to $94.68 Million (23.75% CAGR). Also see Scope Fluidics SA (SCP) cash flow conversion for how efficiently the company converts equity into cash flow.
Scope Fluidics SA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Scope Fluidics SA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check SCP stock price and chart for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
939.20x
Scope Fluidics SA's market cap is 939.20 times its annual revenue
Latest Price to Earnings (P/E) Ratio
1.88x
Scope Fluidics SA's market cap is 1.88 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $10.88 Million | $1.80K | -$4.17 Million | 6043.40x | N/A |
| 2022 | $155.67 Million | $404.00K | $318.49 Million | 385.32x | 0.49x |
| 2023 | $147.04 Million | $516.00K | -$18.79 Million | 284.97x | N/A |
| 2024 | $123.04 Million | $131.00K | $65.42 Million | 939.20x | 1.88x |
Competitor Companies of SCP by Market Capitalization
Companies near Scope Fluidics SA in the global market cap rankings as of September 16, 2026. Review SCP intangible-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Scope Fluidics SA by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #88 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #161 globally with a market cap of $147.88 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #476 globally with a market cap of $56.70 Billion USD ( CN¥387.49 Billion CNY).
- Natera Inc (NASDAQ:NTRA): Ranked #578 globally with a market cap of $47.01 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #88 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $641.39 |
| #161 | Danaher Corporation | NYSE:DHR | $147.88 Billion | $209.36 |
| #476 | WuXi AppTec Co Ltd | SHG:603259 | $56.70 Billion | CN¥156.67 |
| #578 | Natera Inc | NASDAQ:NTRA | $47.01 Billion | $350.78 |
Scope Fluidics SA Historical Marketcap From 2017 to 2026
Between 2017 and today, Scope Fluidics SA's market cap moved from $10.88 Million to $ 94.68 Million, with a yearly change of 23.75%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | zł94.68 Million | -7.34% |
| 2025 | zł102.18 Million | -16.95% |
| 2024 | zł123.04 Million | -16.33% |
| 2023 | zł147.04 Million | -5.54% |
| 2022 | zł155.67 Million | +52.13% |
| 2021 | zł102.33 Million | +1.04% |
| 2020 | zł101.28 Million | +125.00% |
| 2019 | zł45.01 Million | +300.00% |
| 2018 | zł11.25 Million | +3.45% |
| 2017 | zł10.88 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Scope Fluidics SA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $94.68 Million USD |
| MoneyControl | $94.68 Million USD |
| MarketWatch | $94.68 Million USD |
| marketcap.company | $94.68 Million USD |
| Reuters | $94.68 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Scope Fluidics SA
Scope Fluidics S.A., a biotechnology company, designs and develops projects based on microfluidic technologies in medical diagnostics and healthcare in Poland. The company offers BacterOMIC, an antibiotic susceptibility testing. Scope Fluidics S.A. was founded in 2010 and is based in Warsaw, Poland.